ResMed Net Debt from 2010 to 2026

RMD Stock

USD 259.62 3.92 1.49%

ResMed's Net Debt is increasing over the years with slightly volatile fluctuation. Overall, Net Debt is projected to go to about -390.7 M this year. Net Debt is the total debt of ResMed Inc minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

1993-06-30

Previous Quarter

-537.5 M

Current Value

-415.2 M

Quarterly Volatility

510.9 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check ResMed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ResMed's main balance sheet or income statement drivers, such as Depreciation And Amortization of 284.7 M, Interest Expense of 11.9 M or Total Revenue of 6.2 B, as well as many indicators such as Price To Sales Ratio of 4.31, Dividend Yield of 0.0134 or PTB Ratio of 4.78. ResMed financial statements analysis is a perfect complement when working with ResMed Valuation or Volatility modules.

Build AI portfolio with ResMed Stock

Check out the analysis of ResMed Correlation against competitors.

Analyzing ResMed's Net Debt over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Debt has evolved provides context for assessing ResMed's current valuation and future prospects.

Latest ResMed's Net Debt Growth Pattern

Below is the plot of the Net Debt of ResMed Inc over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. ResMed's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ResMed's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

ResMed Net Debt Regression Statistics

	Arithmetic Mean	150,946,590
	Geometric Mean	350,098,957
	Coefficient Of Variation	418.11
	Mean Deviation	539,102,268
	Median	92,753,000
	Standard Deviation	631,117,832
	Sample Variance	398309.7T
	Range	2B
	R-Value	0.28
	Mean Square Error	391318.7T
	R-Squared	0.08
	Significance	0.27
	Slope	35,117,972
	Total Sum of Squares	6372955.5T

ResMed Net Debt History

	2026	-390.7 M
	2025	-411.3 M
	2024	-357.6 M
	2023	635.6 M
	2022	1.4 B
	2021	643.8 M
	2020	498.4 M

Other Fundumenentals of ResMed Inc

Net Debt To E B I T D A

ResMed Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Short Term Investments	Common Stock	Good Will	Property Plant Equipment	Long Term Debt	Treasury Stock	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Long Term Investments	Net Invested Capital	Cash And Equivalents	Net Working Capital	Capital Stock
Total Assets		0.98	0.1	0.99	0.98	0.99	0.9	0.94	-0.19	0.87	0.72	0.59	0.98	0.76	0.41	-0.54	0.99	-0.37	0.5	0.88	-0.26	-0.47	0.76	0.85	0.58	0.74	0.72
Total Stockholder Equity	0.98		-0.05	1.0	0.99	0.99	0.81	0.97	-0.21	0.77	0.67	0.57	0.94	0.73	0.25	-0.45	0.97	-0.23	0.35	0.85	-0.27	-0.46	0.67	0.86	0.66	0.81	0.77
Net Debt	0.1	-0.05		-0.01	-0.04	0.0	0.47	-0.2	-0.15	0.55	0.47	-0.05	0.29	0.17	0.81	-0.41	0.14	-0.64	0.76	0.24	0.05	-0.23	0.58	0.03	-0.61	-0.43	-0.33
Retained Earnings	0.99	1.0	-0.01		0.99	0.99	0.84	0.96	-0.18	0.8	0.67	0.59	0.95	0.73	0.3	-0.5	0.98	-0.29	0.39	0.87	-0.23	-0.46	0.7	0.84	0.64	0.78	0.76
Accounts Payable	0.98	0.99	-0.04	0.99		0.98	0.82	0.95	-0.2	0.79	0.67	0.57	0.94	0.71	0.27	-0.48	0.97	-0.3	0.35	0.86	-0.26	-0.47	0.69	0.83	0.66	0.78	0.77
Net Receivables	0.99	0.99	0.0	0.99	0.98		0.85	0.95	-0.18	0.81	0.65	0.62	0.95	0.74	0.31	-0.55	0.97	-0.34	0.4	0.88	-0.21	-0.46	0.71	0.81	0.61	0.74	0.74
Total Liab	0.9	0.81	0.47	0.84	0.82	0.85		0.75	-0.14	0.98	0.75	0.55	0.94	0.71	0.73	-0.69	0.89	-0.67	0.8	0.85	-0.18	-0.44	0.87	0.7	0.31	0.46	0.5
Total Current Assets	0.94	0.97	-0.2	0.96	0.95	0.95	0.75		-0.07	0.67	0.53	0.62	0.85	0.7	0.2	-0.43	0.91	-0.15	0.31	0.78	-0.28	-0.32	0.53	0.82	0.76	0.87	0.79
Short Term Debt	-0.19	-0.21	-0.15	-0.18	-0.2	-0.18	-0.14	-0.07		-0.22	-0.49	0.06	-0.27	-0.17	-0.07	-0.08	-0.28	0.02	0.03	-0.17	0.23	0.53	-0.36	-0.24	0.07	0.0	-0.14
Intangible Assets	0.87	0.77	0.55	0.8	0.79	0.81	0.98	0.67	-0.22		0.81	0.48	0.94	0.66	0.74	-0.64	0.88	-0.73	0.79	0.83	-0.17	-0.5	0.91	0.68	0.22	0.38	0.46
Short Term Investments	0.72	0.67	0.47	0.67	0.67	0.65	0.75	0.53	-0.49	0.81		0.29	0.82	0.65	0.53	-0.29	0.79	-0.38	0.52	0.76	-0.48	-0.64	0.85	0.8	0.18	0.37	0.5
Common Stock	0.59	0.57	-0.05	0.59	0.57	0.62	0.55	0.62	0.06	0.48	0.29		0.51	0.85	0.32	-0.74	0.55	-0.28	0.33	0.75	-0.1	-0.22	0.55	0.58	0.28	0.31	0.6
Good Will	0.98	0.94	0.29	0.95	0.94	0.95	0.94	0.85	-0.27	0.94	0.82	0.51		0.73	0.52	-0.54	0.98	-0.48	0.58	0.89	-0.23	-0.53	0.85	0.83	0.46	0.62	0.65
Property Plant Equipment	0.76	0.73	0.17	0.73	0.71	0.74	0.71	0.7	-0.17	0.66	0.65	0.85	0.73		0.41	-0.68	0.76	-0.21	0.41	0.89	-0.32	-0.44	0.75	0.79	0.21	0.39	0.58
Long Term Debt	0.41	0.25	0.81	0.3	0.27	0.31	0.73	0.2	-0.07	0.74	0.53	0.32	0.52	0.41		-0.59	0.39	-0.76	0.97	0.48	0.0	-0.08	0.69	0.33	-0.18	-0.04	0.06
Treasury Stock	-0.54	-0.45	-0.41	-0.5	-0.48	-0.55	-0.69	-0.43	-0.08	-0.64	-0.29	-0.74	-0.54	-0.68	-0.59		-0.51	0.59	-0.61	-0.67	-0.09	0.24	-0.64	-0.28	0.09	0.01	-0.14
Current Deferred Revenue	0.99	0.97	0.14	0.98	0.97	0.97	0.89	0.91	-0.28	0.88	0.79	0.55	0.98	0.76	0.39	-0.51		-0.36	0.47	0.89	-0.32	-0.56	0.79	0.85	0.53	0.69	0.7
Net Tangible Assets	-0.37	-0.23	-0.64	-0.29	-0.3	-0.34	-0.67	-0.15	0.02	-0.73	-0.38	-0.28	-0.48	-0.21	-0.76	0.59	-0.36		-0.77	-0.41	-0.14	0.22	-0.64	-0.12	0.08	0.13	-0.08
Long Term Debt Total	0.5	0.35	0.76	0.39	0.35	0.4	0.8	0.31	0.03	0.79	0.52	0.33	0.58	0.41	0.97	-0.61	0.47	-0.77		0.51	-0.07	-0.09	0.67	0.34	-0.09	0.06	0.08
Capital Surpluse	0.88	0.85	0.24	0.87	0.86	0.88	0.85	0.78	-0.17	0.83	0.76	0.75	0.89	0.89	0.48	-0.67	0.89	-0.41	0.51		-0.19	-0.48	0.88	0.86	0.35	0.5	0.72
Deferred Long Term Liab	-0.26	-0.27	0.05	-0.23	-0.26	-0.21	-0.18	-0.28	0.23	-0.17	-0.48	-0.1	-0.23	-0.32	0.0	-0.09	-0.32	-0.14	-0.07	-0.19		0.43	-0.14	-0.39	-0.18	-0.27	-0.19
Short Long Term Debt	-0.47	-0.46	-0.23	-0.46	-0.47	-0.46	-0.44	-0.32	0.53	-0.5	-0.64	-0.22	-0.53	-0.44	-0.08	0.24	-0.56	0.22	-0.09	-0.48	0.43		-0.54	-0.43	-0.04	-0.14	-0.29
Long Term Investments	0.76	0.67	0.58	0.7	0.69	0.71	0.87	0.53	-0.36	0.91	0.85	0.55	0.85	0.75	0.69	-0.64	0.79	-0.64	0.67	0.88	-0.14	-0.54		0.68	0.07	0.21	0.48
Net Invested Capital	0.85	0.86	0.03	0.84	0.83	0.81	0.7	0.82	-0.24	0.68	0.8	0.58	0.83	0.79	0.33	-0.28	0.85	-0.12	0.34	0.86	-0.39	-0.43	0.68		0.56	0.75	0.84
Cash And Equivalents	0.58	0.66	-0.61	0.64	0.66	0.61	0.31	0.76	0.07	0.22	0.18	0.28	0.46	0.21	-0.18	0.09	0.53	0.08	-0.09	0.35	-0.18	-0.04	0.07	0.56		0.91	0.81
Net Working Capital	0.74	0.81	-0.43	0.78	0.78	0.74	0.46	0.87	0.0	0.38	0.37	0.31	0.62	0.39	-0.04	0.01	0.69	0.13	0.06	0.5	-0.27	-0.14	0.21	0.75	0.91		0.8
Capital Stock	0.72	0.77	-0.33	0.76	0.77	0.74	0.5	0.79	-0.14	0.46	0.5	0.6	0.65	0.58	0.06	-0.14	0.7	-0.08	0.08	0.72	-0.19	-0.29	0.48	0.84	0.81	0.8

Click cells to compare fundamentals

About ResMed Financial Statements

ResMed stakeholders use historical fundamental indicators, such as ResMed's Net Debt, to determine how well the company is positioned to perform in the future. Although ResMed investors may analyze each financial statement separately, they are all interrelated. For example, changes in ResMed's assets and liabilities are reflected in the revenues and expenses on ResMed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ResMed Inc. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	-411.3 M	-390.7 M
Net Debt To EBITDA	(0.17)	(0.18)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:

How To Invest In ResMed

Details

Is ResMed Stock a good investment?

Details

What is ResMed's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of ResMed Correlation against competitors.

You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Will Health Care Equipment & Supplies sector continue expanding? Could ResMed diversify its offerings? Factors like these will boost the valuation of ResMed. Anticipated expansion of ResMed directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every ResMed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.

Quarterly Earnings Growth

0.145

Dividend Share

2.26

Earnings Share

10.12

Revenue Per Share

36.896

Quarterly Revenue Growth

0.11

ResMed Inc's market price often diverges from its book value, the accounting figure shown on ResMed's balance sheet. Smart investors calculate ResMed's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since ResMed's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.

It's important to distinguish between ResMed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding ResMed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

ResMed Net Debt from 2010 to 2026

Latest ResMed's Net Debt Growth Pattern

ResMed Net Debt Regression Statistics

ResMed Net Debt History

Other Fundumenentals of ResMed Inc

ResMed Net Debt component correlations

About ResMed Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY